KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
135 hedge funds and large institutions have $898M invested in Chinook Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 56 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
23% more capital invested
Capital invested by funds: $727M → $898M (+$170M)
Holders
135
Holding in Top 10
9
Calls
$13.9M
Puts
$59K
Top Buyers
| 1 | +$20.9M | |
| 2 | +$20.4M | |
| 3 | +$18.6M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$15.4M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$9.97M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$19M | |
| 3 | -$16.4M | |
| 4 |
VA
VR Adviser
New York
|
-$13.9M |
| 5 |
AC
Armistice Capital
New York
|
-$12.4M |